Identification of Radil as a Ras binding partner and putative activator

Ras genes are among the most frequently mutated oncogenes in human malignancies. To date, there are no successful anticancer drugs in the clinic that target Ras proteins or their pathways. Therefore, it is imperative to identify and characterize new components that regulate Ras activity or mediate i...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Byeong Hyeok, Kou, Ziyue, Colon, Tania Marlyn, Chen, Chih-Hong, Chen, Yuan, Dai, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949112/
https://www.ncbi.nlm.nih.gov/pubmed/33482197
http://dx.doi.org/10.1016/j.jbc.2021.100314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7949112/
https://www.ncbi.nlm.nih.gov/pubmed/33482197
http://dx.doi.org/10.1016/j.jbc.2021.100314

Ejemplares similares